Table 3.
MRI negative predictive value of clinically significant, Grade Group 2 or greater prostate cancer detection according to PSAD and biopsy history
| PSAD (ng/ml/cc) | No. MRI Neg Predictive Value/Total No. (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| Overall | Biopsy Naïve |
Prior Neg Biopsy |
Prior Pos Biopsy |
|||||
| 0.15 or Greater | 14/35 | (60) | 2/7 | (71) | 5/17 | (71) | 7/11 | (36) |
| Less than 0.15 | 10/99 | (90) | 8/40 | (80) | 0/43 | (100) | 2/16 | (88) |
| p Value | <0.001 | 0.63 | 0.001 | 0.012 | ||||
| 0.15 or Greater | 14/35 | (60) | 2/7 | (71) | 5/17 | (71) | 7/11 | (36) |
| 0.10—Less than 0.15 | 6/33 | (82) | 4/13 | (69) | 0/13 | (100) | 2/7 | (71) |
| Less than 0.10 | 4/66 | (94) | 4/27 | (85) | 0/30 | (100) | 0/9 | (100) |
| p Value | <0.001 | 0.53 | 0.001 | 0.009 | ||||